Sign Up Today and Learn More About Owlet Baby Care Stock
Invest in or calculate the value of your shares in Owlet Baby Care or other pre-IPO companies through EquityZen's platform.
About Owlet Baby Care Stock
Founded
2013
Headquarters
Lehi, UT, US
Total Funding
47.0M
Industries
Hardware, Software, Community and Lifestyle
The Owlet Baby Monitor is a proactive health monitor for sleeping infants that allows parents to view their child's vital signs in real time. Owlet will alert the parent if there are low blood oxygen and heart rate levels giving parents peace of mind knowing that their baby is watched over.
Owlet Baby Care Press Mentions
Stay in the know about the latest news on Owlet Baby Care
Owlet Baby Care Announces Dream Lab™: An Innovative, Personalized Video Sleep Course for Infants
pr • Oct 31, 2019
Why Top Execs Are Joining Owlet Baby Care
prweb • Sep 23, 2019
Owlet Baby Care Named the Exclusive Presenting Sponsor of the Biggest Baby Shower Ever
prnewswire • May 28, 2019
Baby tech startup secures $24M Series B
pitchbook • May 09, 2018
Owlet Raises $24M in Series B Funding
finsmes • May 08, 2018
Investors in Owlet Baby Care
Discover investors in Owlet Baby Care stock and explore their portfolio companies
Owlet Baby Care Management
Leadership team at Owlet Baby Care
Co-Founder & Chief Executive Officer
Kurt Workman
Co-Founder & Chief Operating Officer
Jacob Colvin
Join now and verify your accreditation status to gain access to:
- Owlet Baby Care Current Valuation
- Owlet Baby Care Stock Price
- Owlet Baby Care Management
- Available deals in Owlet Baby Care and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Owlet Baby Care Cap Table and Funding History by Share Class and Liquidity Preferences
- Owlet Baby Care Revenue and Financials
- Owlet Baby Care Highlights
- Owlet Baby Care Business Model
- Owlet Baby Care Risk Factors
- Owlet Baby Care Research Report from SACRA Research
Trading Owlet Baby Care Stock
How to invest in Owlet Baby Care stock?
Accredited investors can buy pre-IPO stock in companies like Owlet Baby Care through EquityZen funds. These investments are made available by existing Owlet Baby Care shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Owlet Baby Care stock?
Shareholders can sell their Owlet Baby Care stock through EquityZen's private company marketplace. EquityZen's network includes over 380K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 47K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."